Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design

Background: Same-day esophagogastroduodenoscopy and colonoscopy procedures under sedation have been increasingly performed. This study aims to assess the effects of esketamine combined with ciprofol (a novel anesthetic/sedative agent) or propofol on respiratory and hemodynamic adverse events in pati...

Full description

Bibliographic Details
Main Authors: Yu-qin Long, Chang-dong Feng, Yun-ying Ding, Xiao-mei Feng, Hong Liu, Fu-hai Ji, Ke Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.821691/full
_version_ 1818392757548351488
author Yu-qin Long
Yu-qin Long
Chang-dong Feng
Chang-dong Feng
Yun-ying Ding
Yun-ying Ding
Xiao-mei Feng
Hong Liu
Fu-hai Ji
Fu-hai Ji
Ke Peng
Ke Peng
author_facet Yu-qin Long
Yu-qin Long
Chang-dong Feng
Chang-dong Feng
Yun-ying Ding
Yun-ying Ding
Xiao-mei Feng
Hong Liu
Fu-hai Ji
Fu-hai Ji
Ke Peng
Ke Peng
author_sort Yu-qin Long
collection DOAJ
description Background: Same-day esophagogastroduodenoscopy and colonoscopy procedures under sedation have been increasingly performed. This study aims to assess the effects of esketamine combined with ciprofol (a novel anesthetic/sedative agent) or propofol on respiratory and hemodynamic adverse events in patients undergoing same-day bidirectional endoscopy.Methods: This is a prospective, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial. A total of 180 adult patients scheduled for same-day bidirectional endoscopy under sedation will be randomized, in a 1:1:1:1 ratio, to receive 1 of 4 sedation regimens: 1) ciprofol and esketamine, 2) propofol and esketamine, 3) ciprofol and normal saline placebo, or 4) propofol and normal saline placebo. The primary outcome is a composite of desaturation [peripheral oxygen saturation (SpO2) < 95%] and hypotension [mean blood pressure (MBP) < 65 mmHg or decrease in MBP ≥20% of baseline] during the sedation and in the recovery room. Secondary outcomes include episodes of desaturation, severe desaturation (SpO2 < 90%), hypotension, severe hypotension (decrease in MBP ≥30% of baseline), bradycardia, postoperative nausea and vomiting, dizziness or headache, hallucination or nightmare, injection pain, pain scores and fatigue scores, endoscopist satisfaction, and patient satisfaction. Data will be analyzed on the modified intention-to-treat basis.Discussion: We hypothesize that esketamine as an adjuvant to ciprofol or propofol sedation would improve cardiorespiratory stability. In addition, the potential interactions between interventions will be explored using the factorial design. The results of this trial will provide evidence for daily practice of sedation regimens for same-day bidirectional endoscopy.Clinical Trial Registration: Chinese Clinical Trials Registry, Identifier ChiCTR2100052523.
first_indexed 2024-12-14T05:34:29Z
format Article
id doaj.art-c8e2f5d044914a759b139c30f0e93f8f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-14T05:34:29Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-c8e2f5d044914a759b139c30f0e93f8f2022-12-21T23:15:14ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-03-011310.3389/fphar.2022.821691821691Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial DesignYu-qin Long0Yu-qin Long1Chang-dong Feng2Chang-dong Feng3Yun-ying Ding4Yun-ying Ding5Xiao-mei Feng6Hong Liu7Fu-hai Ji8Fu-hai Ji9Ke Peng10Ke Peng11Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, ChinaInstitute of Anesthesiology, Soochow University, Suzhou, ChinaDepartment of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, ChinaInstitute of Anesthesiology, Soochow University, Suzhou, ChinaDepartment of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, ChinaInstitute of Anesthesiology, Soochow University, Suzhou, ChinaDepartment of Anesthesiology, University of Utah, Salt Lake City, UT, United StatesDepartment of Anesthesiology and Pain Medicine, University of California Davis Health System, Sacramento, CA, United StatesDepartment of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, ChinaInstitute of Anesthesiology, Soochow University, Suzhou, ChinaDepartment of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, ChinaInstitute of Anesthesiology, Soochow University, Suzhou, ChinaBackground: Same-day esophagogastroduodenoscopy and colonoscopy procedures under sedation have been increasingly performed. This study aims to assess the effects of esketamine combined with ciprofol (a novel anesthetic/sedative agent) or propofol on respiratory and hemodynamic adverse events in patients undergoing same-day bidirectional endoscopy.Methods: This is a prospective, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial. A total of 180 adult patients scheduled for same-day bidirectional endoscopy under sedation will be randomized, in a 1:1:1:1 ratio, to receive 1 of 4 sedation regimens: 1) ciprofol and esketamine, 2) propofol and esketamine, 3) ciprofol and normal saline placebo, or 4) propofol and normal saline placebo. The primary outcome is a composite of desaturation [peripheral oxygen saturation (SpO2) < 95%] and hypotension [mean blood pressure (MBP) < 65 mmHg or decrease in MBP ≥20% of baseline] during the sedation and in the recovery room. Secondary outcomes include episodes of desaturation, severe desaturation (SpO2 < 90%), hypotension, severe hypotension (decrease in MBP ≥30% of baseline), bradycardia, postoperative nausea and vomiting, dizziness or headache, hallucination or nightmare, injection pain, pain scores and fatigue scores, endoscopist satisfaction, and patient satisfaction. Data will be analyzed on the modified intention-to-treat basis.Discussion: We hypothesize that esketamine as an adjuvant to ciprofol or propofol sedation would improve cardiorespiratory stability. In addition, the potential interactions between interventions will be explored using the factorial design. The results of this trial will provide evidence for daily practice of sedation regimens for same-day bidirectional endoscopy.Clinical Trial Registration: Chinese Clinical Trials Registry, Identifier ChiCTR2100052523.https://www.frontiersin.org/articles/10.3389/fphar.2022.821691/fullciprofolpropofolesketaminesedationbidirectional endoscopy
spellingShingle Yu-qin Long
Yu-qin Long
Chang-dong Feng
Chang-dong Feng
Yun-ying Ding
Yun-ying Ding
Xiao-mei Feng
Hong Liu
Fu-hai Ji
Fu-hai Ji
Ke Peng
Ke Peng
Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design
Frontiers in Pharmacology
ciprofol
propofol
esketamine
sedation
bidirectional endoscopy
title Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design
title_full Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design
title_fullStr Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design
title_full_unstemmed Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design
title_short Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design
title_sort esketamine as an adjuvant to ciprofol or propofol sedation for same day bidirectional endoscopy protocol for a randomized double blind controlled trial with factorial design
topic ciprofol
propofol
esketamine
sedation
bidirectional endoscopy
url https://www.frontiersin.org/articles/10.3389/fphar.2022.821691/full
work_keys_str_mv AT yuqinlong esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT yuqinlong esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT changdongfeng esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT changdongfeng esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT yunyingding esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT yunyingding esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT xiaomeifeng esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT hongliu esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT fuhaiji esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT fuhaiji esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT kepeng esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign
AT kepeng esketamineasanadjuvanttociprofolorpropofolsedationforsamedaybidirectionalendoscopyprotocolforarandomizeddoubleblindcontrolledtrialwithfactorialdesign